RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial

The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial

Add to Collection
RCTs R Retnakaran, C Ye, A Emery, CK Kramer… - Nature …, 2022 - nature.com

Chapter : Section2, Section9
Journal Year : 2022
Cited by : 5

… In this context, we hypothesized that combining basal insulin with a GLP1-RA in early T2DM … -cell function and diabetes remission, while limiting the risks of hypoglycemia and weight …..... Read More

Keywords : ['randomized clinical trial', 'early type diabetes', 'basal insulin therapy', 'target remission', 'metabolic effect', 'add exenatide']
PubMed Link : https://www.nature.com/articles/s41467-022-33867-9
Google Scholar Link : https://scholar.google.com/scholar?cites=7804008385271823647&as_sdt=2005&sciodt=0,5&hl=en&num=20